Egle Ramelyte

20PUBLICATIONS
66CO-AUTHORS
Medical molecular engineering of nucleic acids and proteinsTumour immunologyMolecular targetsPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (20)

|Jul 13, 2026
An anti-PMEL antibody-drug conjugate with a Gq/11 inhibitor payload in GNAQ/GNA11-mutant melanomas: a phase 1 trial.

|Jun 09, 2026
Depicting the Immunological Landscape of Basal Cell Carcinoma Subtypes.

|Apr 27, 2026
Re-Exposure of a PD-1 Inhibitor After Previous Immune-Related Adverse Events.

|Mar 28, 2026
Advantages of MelArray over Oncomine Focus Assay for Mutation Analysis in Melanoma.

Andrew E Quacoe, Sandra N Freiberger, Mitchell P Levesque

|Feb 25, 2026
Safety of Multi-Omics-Guided Therapy in Advanced Melanoma: A Matched Comparative Cohort Analysis.

Benedict Gosztonyi, Tarun Mehra, Gabriele Gut

|Jan 10, 2026
Neoadjuvant Therapy in Resectable Advanced Melanoma: Swiss Real-World Data.

Ann-Kathrin Blumenröther, Yongxing Fang, Tamara El Saadany

Pageof 4

Frequent Collaborators

16 joint publications

Reinhard Dummer

8 joint publications

Mitchell P Levesque

3 joint publications

Patrick Turko

3 joint publications

Sandra N Freiberger